John-Paul W. Felter - 23 Feb 2026 Form 4 Insider Report for HUMANA INC (HUM)

Reporting relationship: SVP, Chief Accting Off & Cont.
Issuer ticker: HUM
Reported as of: 23 Feb 2026
Net transaction value: -$14,874
SEC form: 4
Accepted by SEC: 25 Feb 2026, 16:04:34 UTC
Prior SEC filing: 17 Dec 2025
Source filing: View source filing
Reporting owner signature: John-Paul W. Felter

Key filing fact

John-Paul W. Felter filed Form 4 for HUMANA INC (HUM) on 25 Feb 2026.

Key facts

This page summarizes John-Paul W. Felter's Form 4 filing for HUMANA INC (HUM).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 25 Feb 2026, 16:04.

Change

Previous filing in this sequence was filed on 17 Dec 2025.
Current net transaction value: -$14,874.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001936662 Primary reporting owner

Felter John-Paul W.

Relationship: SVP, Chief Accting Off & Cont.
Address: HUMANA INC., 101 E. MAIN STREET, LOUISVILLE
Signature: John-Paul W. Felter
Signature date: 25 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HUM transaction

Humana Common

Award

Transaction value: $0
Shares: +5,669
Change %: +327%
Price: $0.000000
Shares after: 7,403
Date: 23 Feb 2026
Ownership: Direct

HUM transaction

Humana Common

Options Exercise

Transaction value: $0
Shares: +165
Change %: +2.2%
Price: $0.000000
Shares after: 7,568
Date: 24 Feb 2026
Ownership: Direct
Footnotes: F2

HUM transaction

Humana Common

Tax liability

Transaction value: $14,874
Shares: -84
Change %: -1.1%
Price: $177.08
Shares after: 7,484
Date: 24 Feb 2026
Ownership: Direct
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Includes 6,417 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Footnote F2

Includes Performance Stock Units not required to be reported until vesting on 2/24/26.

Footnote F3

Shares disposed of represent payment for tax liability on performance stock units vesting 2/24/26. No value was received in return.